Status:

RECRUITING

Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Psychotic Disorders

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The proposed clinical trial aims to examine the efficacy of an online-based self-help intervention for auditory hallucinations in persons with psychotic disorders. The intervention is primarily based ...

Detailed Description

The investigators will identify eligible participants at various outpatient departments, suitable support groups, online platforms, and social media. An eligibility screening (in person or by telephon...

Eligibility Criteria

Inclusion

  • current experience of auditory hallucinations that appear at least once a week (measured over the PSYRATS).
  • diagnosis of a schizophrenia-spectrum disorder according to the Diagnostical and Statistical Manual (5th edition) and/or the International Statistical Classification of Diseases and Related Health Problems (ICD-10), code F2x.x. In case of a suspected diagnosis or missing clinical diagnostic, we will apply the Mini-International Neuropsychiatric Interview (M.I.N.I.).
  • stable psychiatric medication over at least one month, slight changes of dosage are allowed and will be evaluated by a trained psychiatrist.
  • ability to give informed consent.
  • willingness and ability to engage in the psychotherapeutic self-help intervention.
  • availability of a mobile device and internet access.

Exclusion

  • neurological disorders that may affect cognitive functioning and condition after severe traumatic brain injury.
  • acute suicidality, assessed at the previous screening procedures.
  • auditory hallucinations in the context of other primary diagnoses e.g., post-traumatic stress disorder or borderline personality disorder.
  • acute substance abuse other than nicotine and prescribed medication.
  • current electroconvulsive therapy.
  • current inpatient or day-care treatment.

Key Trial Info

Start Date :

June 13 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 15 2025

Estimated Enrollment :

86 Patients enrolled

Trial Details

Trial ID

NCT06186570

Start Date

June 13 2024

End Date

December 15 2025

Last Update

June 14 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin

Berlin, Germany, 12203